Abstract:Metabolic skeletal disorders remain a major clinical challenge. The complexity of this disease requires a strategy to address the net effects of both inflammation and impaired bone formation. microRNA-based gene therapy provides several therapeutic advantages to tackle these issues. Herein, we describe a microRNA-21 (miR-21) delivery system with an additional therapeutic effect from that of the delivery carrier itself. Poly (salicylic acid) (PSA) is, for the first time, synthesized via polycondensation of salicylic acid (SA), a bioactive ingredient widely used for anti-inflammation in medicine. PSA can self-assemble into nanoparticles (PSA-NPs) and can effectively deliver genes both in vitro and in vivo. The carrier was then attached to repetitive sequences of aspartate, serine, serine (DSS)(6) for delivering miRNAs specifically to bone-formation surfaces. In vitro studies showed that miR-21@PSA-NP could effectively realize the intracellular delivery of miR-21 with low toxicity, while in vivo results indicated that the miR-21@PSANP-DSS6 prolonged blood circulation time, enhanced bone accumulation, and significantly improved the efficacy of miR-21-based bone anabolic therapy in osteoporotic mice. The constructed delivery system (miR-21@PSA-NP-DSS6) inherited the advantages of both SA and miR-21, which could ameliorate boneinflamed niche and rescued the impaired bone formation ability. The synergy of anti-inflammatory and pro-osteogenic effects significantly improved trabecular bone microstructure in osteoporotic mice. Statement of significance The complexity of metabolic skeletal disorders requires a strategy to address the net effects of both inflammation and impaired bone formation. microRNA-based gene therapy provides several therapeutic advantages to tackle these issues. We develop a novel microRNA-21 delivery system with additional therapeutic effect from that of the gene carrier itself. Poly (salicylic acid) (PSA) nanoparticles, for the first time, synthesized via polycondensation of salicylic acid and can effectively deliver genes both in vitro and in vivo. The constructed delivery system (miR-21@PSA-NP-DSS6) inherited the advantages of both SA (commonly used anti-inflammation drug in medicine) and miR-21 (a pro-osteogenic molecule), which could ameliorate bone-inflamed niche, rescued impaired bone formation ability and significantly improved trabecular bone microstructure in osteoporotic mice. (C) 2021 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Construction of Multi‐Module RNA Nanoparticles Harboring miRNA, AIE, and CH6 Aptamer for Bone Targeting and Bone Anabolic Therapy

Aptamer-functionalized Lipid Nanoparticles Targeting Osteoblasts As a Novel RNA Interference–based Bone Anabolic Strategy

A Delivery System Targeting Bone Formation Surfaces to Facilitate RNAi-based Anabolic Therapy

Osteoblast-Targeting-Peptide Modified Nanoparticle for Sirna/Microrna Delivery

Cell-free 3D scaffold with two-stage delivery of miRNA-26a to regenerate critical-sized bone defects

Dual Scaffold Delivery of miR-210 Mimic and miR-16 Inhibitor Enhances Angiogenesis and Osteogenesis to Accelerate Bone Healing

Hierarchical Assembly of Nanostructured Coating for Sirna-Based Dual Therapy of Bone Regeneration and Revascularization.

A Delivery System Specifically Approaching Bone Resorption Surfaces to Facilitate Therapeutic Modulation of Micrornas in Osteoclasts.

The promotion of bone regeneration through positive regulation of angiogenic-osteogenic coupling using microRNA-26a

Development of miR-26a-activated scaffold to promote healing of critical-sized bone defects through angiogenic and osteogenic mechanisms

A Tetrahedral DNA Nanostructure-Mediated Mirna Inhibitor Delivery System: Type H Vessel-Related Bone Healing During Distraction Osteogenesis

Salicylic Acid-Based Nanomedicine with Self-Immunomodulatoryactivity Facilitates Microrna Therapy for Metabolic Skeletal Disorders

An Injectable Mirna-Activated Matrix for Effective Bone Regeneration in Vivo

Bioswitchable Delivery of microRNA by Framework Nucleic Acids: Application to Bone Regeneration

Delivery of Therapeutic Mirnas Using Nanoscale Zeolitic Imidazolate Framework for Accelerating Vascularized Bone Regeneration

Delivery of MiR335‐5p‐Pendant Tetrahedron DNA Nanostructures Using an Injectable Heparin Lithium Hydrogel for Challenging Bone Defects in Steroid‐Associated Osteonecrosis

Incorporation of Osteogenic and Angiogenic Small Interfering RNAs into Chitosan Sponge for Bone Tissue Engineering.

SDSSD Peptide Modified Polyvinylamine − A Novel Bone-Targeting RNA Delivery System

The osteogenic and angiogenic potential of microRNA-26a delivered via a non-viral delivery peptide for bone repair

Bone tissue engineering based on sustained release of MiR29c-modified framework nucleic acids from an injectable hydrogel

Aptamer-immobilized bone-targeting nanoparticles in situ reduce sclerostin for osteoporosis treatment